Photodynamic treatment of normal endothelial cells or glioma cells in vitro.
Photodynamic therapy is based on the interaction of a sensitizer (hematoporphyrin derivative) selectively retained by tumor cells, which becomes toxic after light exposure. We studied the influence of exogenous prostaglandins and indomethacin on photodynamic therapy of normal human endothelial cells and glioma cells. Although differing in origin and kinetic properties, endothelial cells exhibited photodynamic therapy sensitivity quite comparable to that of C6 cells. However, in contrast to studies performed using radiotherapy, exogenous prostaglandins decreased rather than protected the surviving fraction of both cell types treated by photodynamic therapy. Indomethacin, a potent inhibitor of endogenous prostaglandin synthesis, increased the surviving fraction of C6 glioma cells but not that of endothelial cells. Exogenous or endogenous prostaglandins seem to influence in vitro photodynamic therapy in a different way than does radiotherapy.
Foultier
M T
MT
Laser Department, Hôpital Laennec, Nantes, France.
Patrice
T
T
Yactayo
S
S
Lajat
Y
Y
Resche
F
F
D000818:Animals; D016923:Cell Death / Q000187:drug effects; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects*; D005910:Glioma / Q000188:drug therapy*; D006414:Hematoporphyrin Photoradiation; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D051379:Mice; D016595:Misoprostol / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D016595:Misoprostol; D007213:Indomethacin